UPB — Upstream Bio Balance Sheet
0.000.00%
- $450.45m
- -$20.00m
- $2.37m
Annual balance sheet for Upstream Bio, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|
Period Length: | — | — | — |
Source: | PROSPECTUS/A | PROSPECTUS/A | 10-K |
Standards: | USG | USG | USG |
Status: | Final | Final | Final |
Cash and Equivalents | |||
Short Term Investments | |||
Cash and Short Term Investments | 17.1 | 110 | 470 |
Net Total Accounts Receivable | |||
Net Total Receivables | 0.502 | 0.359 | 1.24 |
Prepaid Expenses | |||
Total Other Current Assets | |||
Total Current Assets | 18.3 | 117 | 479 |
Gross Property, Plant And Equipment | |||
Accumulated Depreciation | |||
Net Property, Plant And Equipment | 0.164 | 0.202 | 2.37 |
Other Long Term Assets | |||
Total Assets | 18.5 | 117 | 482 |
Accounts Payable | |||
Accrued Expenses | |||
Notes Payable / Short Term Debt | |||
Total Current Liabilities | 4.86 | 6.51 | 10.7 |
Total Long Term Debt | |||
Total Debt | |||
Total Other Liabilities | |||
Total Liabilities | 11.8 | 9.39 | 11.9 |
Redeemable Preferred Stock | |||
Common Stock | |||
Additional Paid In Capital | |||
Retained Earnings (Accumulated Deficit) | |||
Unrealized Gain / Loss | |||
Total Equity | 6.67 | 108 | 470 |
Total Liabilities & Shareholders' Equity | 18.5 | 117 | 482 |
Total Common Shares Outstanding |